Well, I don’t believe NP will deliver bad news, but it’s hard to believe he’ll announce the halting of the trial for efficacy. It seems he would announce that immediately upon receipt of the DSMB’s decision. I imagine he’ll announce that the DSMB recommended the trial to continue, but I don’t understand why he cant simply release a PR.

The last paragraph seems to indicate that the trial will not be halted, “Management will discuss the recommendations of the Data Safety Monitoring Committee (DSMC).....including a POTENTIAL regulatory path forward.” I’m interested to know what regulatory path to approval that the DSMC recommended.